Juan José Hernando

Summary

Affiliation: University of Bonn
Country: Germany

Publications

  1. ncbi Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany
    Cancer Immunol Immunother 51:45-52. 2002
  2. ncbi Dendritic cell-based vaccines in breast and gynaecologic cancer
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    Anticancer Res 23:4293-303. 2003
  3. ncbi Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Germany
    Lancet Oncol 8:451-4. 2007
  4. ncbi Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
    Martin Pölcher
    Department of Gynaecology and Obstetrics, Centre for Integrated Oncology Bonn, Bonn University Medical Centre, Sigmund Freud Str 25, 53105, Bonn, Germany
    Cancer Immunol Immunother 59:909-19. 2010
  5. ncbi The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach
    Tjoung Won Park
    Departmetn of Obstetrics and Gynaecology, University of Bonn, D 53105 Bonn, Germany
    Int J Oncol 24:829-36. 2004

Detail Information

Publications5

  1. ncbi Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany
    Cancer Immunol Immunother 51:45-52. 2002
    ..The treatment was safe, well tolerated, immunologically active and except for local cutaneous hypersensitivity devoid of significant adverse effects...
  2. ncbi Dendritic cell-based vaccines in breast and gynaecologic cancer
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    Anticancer Res 23:4293-303. 2003
    ..In this review, we summarize key biological functions of DC and focus on recent DC-based vaccination trials of breast, ovarian and cervical cancer...
  3. ncbi Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
    Juan José Hernando
    Department of Obstetrics and Gynaecology, University of Bonn, Germany
    Lancet Oncol 8:451-4. 2007
  4. ncbi Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
    Martin Pölcher
    Department of Gynaecology and Obstetrics, Centre for Integrated Oncology Bonn, Bonn University Medical Centre, Sigmund Freud Str 25, 53105, Bonn, Germany
    Cancer Immunol Immunother 59:909-19. 2010
    ....
  5. ncbi The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach
    Tjoung Won Park
    Departmetn of Obstetrics and Gynaecology, University of Bonn, D 53105 Bonn, Germany
    Int J Oncol 24:829-36. 2004
    ..The proposed diagnostic approach is helpful in the identification and management of pelvic tumours of unknown primary origin...